Company news
ImmuPharma plc news in 2026
ImmuPharma plc's news releases, calls and decks from 2026, newest first.
New peer-reviewed publication
September 15, 2026
Bioanalytical CRO partner for Kapiglucagon
August 10, 2026
Thermo Fisher CDMO selected for Kapiglucagon pro
July 22, 2026
2026 Result of annual general meeting
June 25, 2026
University of Murcia research relating to P140
June 24, 2026
Incanthera plc – Corporate Update & Board Changes
June 4, 2026
FINAL RESULTS for the twelve months ended 31 December 2025
May 27, 2026
IMM initiatesIND-Enabling Program for Kapiglucagon
May 5, 2026
Holding(s) in Company
April 10, 2026
Chairman’s Open Letter to Shareholders
April 9, 2026
Result of General Meeting and TVR
April 7, 2026
P140 Program Update
March 27, 2026
Result of WRAP Retail Offer and TVR
March 23, 2026
Publication of Circular
March 19, 2026
‘Investor Meet Company’ presentation on 20 March
March 18, 2026
WRAP Retail Offer for up to £1.5 million
March 17, 2026
Attending JPMorgan Conference & Biotech Showcase
January 6, 2026